Outcomes from a Mechanistic Biomarker Multi-Arm and Randomised Study of Liposomal MTP-PE (mifamurtide) in Metastatic And/or Recurrent Osteosarcoma (Eurosarc-Memos Trial)
BMC Cancer（2022）
关键词
Osteosarcoma,Muramyl tripeptide,Phase II trial,Bayesian,Sarcoma,Bone neoplasm,Rare cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要